Mokhtar Wafaa A, Elsaid Afaf M, Elrefaey Ahmed M, Saleh Marwan Mahmood, Youssef Magdy M
Division of Biochemistry, Department of Chemistry, Faculty of Science, University of Mansoura, Mansoura, Egypt.
Consultant of Biochemistry, Faculty of Medicine, University of Mansoura, Mansoura, Egypt.
Biochem Genet. 2024 Jul 19. doi: 10.1007/s10528-024-10883-6.
Nephrotic syndrome is one of the most prevalent pediatric kidney illnesses seen in pediatric nephrology clinics. Steroid resistance in children with nephrotic syndrome is a primary cause of renal failure and is characterized by nephrotic range proteinuria that does not respond to conventional steroid therapy. The current work was intended to investigate the possible role of the Phospholipase C epsilon 1 (rs7922612) and collagen4 alpha 3 (rs375290088) single nucleotide polymorphisms as risk factors for developing nephrotic syndrome among Egyptian children. The study was conducted on 100 children with nephrotic syndrome and 100 age- and sex-matched healthy individuals. Geno typing was performed by two methods of polymerase chain reaction for the analysis of PLCE1 (rs7922612) and COL4A3 (rs375290088) variants. We observed a higher percentage of the heterozygous and homozygous variant genotypes of PLCE1 (rs7922612) SNP in NS patients in comparison with the controls (P < 0.001 for both). The frequencies of the PLCE1 (rs7922612) variant showed a statistically significant elevated risk of NS using several genetic models, including the dominant (OR = 9.12), recessive (OR = 2.31), and allelic (OR = 1.62) models (P < 0.001 for each). In addition, the PLCE1 (rs7922612) genotypes and alleles frequencies did not differ significantly between SRNS compared to SSNS cases. Furthermore, there was no significant difference regarding COL4A3 (rs375290088) polymorphism, neither between the NS and control groups nor between SDNS and SRNS. PLCE1 (rs7922612) is considered an independent risk factor for nephrotic syndrome in Egyptian pediatrics.COL4A3 (rs375290088) polymorphism is not correlated to Egyptian NS patients.
肾病综合征是儿科肾病诊所中最常见的儿科肾脏疾病之一。肾病综合征患儿的类固醇抵抗是肾衰竭的主要原因,其特征是对传统类固醇治疗无反应的肾病范围蛋白尿。当前的研究旨在调查磷脂酶Cε1(rs7922612)和胶原蛋白4α3(rs375290088)单核苷酸多态性作为埃及儿童患肾病综合征风险因素的可能作用。该研究对100名肾病综合征患儿和100名年龄及性别匹配的健康个体进行。通过两种聚合酶链反应方法对PLCE1(rs7922612)和COL4A3(rs375290088)变体进行基因分型分析。我们观察到,与对照组相比,NS患者中PLCE1(rs7922612)SNP的杂合和纯合变异基因型百分比更高(两者P均<0.001)。使用几种遗传模型,包括显性(OR = 9.12)、隐性(OR = 2.31)和等位基因(OR = 1.62)模型,PLCE1(rs7922612)变体的频率显示NS的风险在统计学上显著升高(每种模型P均<0.001)。此外,与SSNS病例相比,SRNS之间的PLCE1(rs7922612)基因型和等位基因频率没有显著差异。此外,COL4A3(rs375290088)多态性在NS与对照组之间以及SDNS与SRNS之间均无显著差异。PLCE1(rs7922612)被认为是埃及儿科肾病综合征的独立风险因素。COL4A3(rs375290088)多态性与埃及NS患者无关。